tiprankstipranks
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market
Holding OTLC?
Track your performance easily

Oncotelic Therapeutics (OTLC) Technical Analysis

80 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
9Bullish
1Neutral
2Bearish
Oncotelic Therapeutics’s (OTLC) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Oncotelic Therapeutics is a Sell.
Oncotelic Therapeutics’s (OTLC) 20-Day exponential moving average is 0.03, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Buy.
Oncotelic Therapeutics’s (OTLC) 50-Day exponential moving average is 0.03, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Buy.

Oncotelic Therapeutics (OTLC) Pivot Points

Dec 21, 2024, 08:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Fibonacci
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oncotelic Therapeutics (OTLC) Moving Averages

Dec 21, 2024, 08:28 PM
Period
Simple
Exponential
MA5
0.03Buy
0.03Buy
MA10
0.03Buy
0.03Buy
MA20
0.03Buy
0.03Buy
MA50
0.03Neutral
0.03Buy
MA100
0.03Buy
0.03Buy
MA200
0.03Sell
0.03Sell
Oncotelic Therapeutics’s (OTLC) 10-Day exponential moving average is 0.03, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Buy.
Oncotelic Therapeutics’s (OTLC) 100-Day exponential moving average is 0.03, while Oncotelic Therapeutics’s (OTLC) share price is <$0.1, making it a Buy.
Oncotelic Therapeutics’s (OTLC) stock price is <$0.1 and Oncotelic Therapeutics’s (OTLC) 50-day simple moving average is 0.03, creating a Neutral signal.
Oncotelic Therapeutics’s (OTLC) stock price is <$0.1 and Oncotelic Therapeutics’s (OTLC) 100-day simple moving average is 0.03, creating a Buy signal.
Oncotelic Therapeutics’s (OTLC) stock price is <$0.1 and Oncotelic Therapeutics’s (OTLC) 200-day simple moving average is 0.03, creating a Sell signal.

Oncotelic Therapeutics (OTLC) Technical Indicators

Dec 21, 2024, 08:28 PM
Name
Value
Implied Action
RSI (14)
51.87
Neutral
STOCH (9,6)
27.78
Neutral
STOCHRSI (14)
38.89
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
13.84
Buy
Williams %R
-66.67
Buy
CCI (14)
13.82
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
26.98
Sell
ROC
0.00
-
Oncotelic Therapeutics’s (OTLC) Relative Strength Index (RSI) is 51.87, creating a Neutral signal.
Oncotelic Therapeutics’s (OTLC) Trend Strength Indicator (ADX) is 13.84, creating a Buy signal.
Oncotelic Therapeutics’s (OTLC) Commodity Channel Index (CCI) is 13.82, creating a Neutral signal.

FAQ

Is OTLC a Buy, Hold, or Sell?
Based on OTLC’s technical indicators, OTLC is a Buy.
    What is OTLC’s RSI (14)?
    OTLC’s RSI (14) is 51.87, which suggests OTLC is a Neutral.
      What is OTLC’s MACD?
      OTLC’s MACD is <0.01, which suggests OTLC is a Sell.
        What is OTLC’s 5-day moving average?
        OTLC’s 5-day moving average is 0.03, which suggests OTLC is a Buy.
          What is OTLC’s 20-day moving average?
          OTLC 20-day moving average is 0.03, which suggests OTLC is a Buy.
            What is OTLC’s 50-day moving average?
            OTLC’s 50-day moving average is 0.03, which suggests OTLC is a Neutral.
              What is OTLC’s 200-day moving average?
              OTLC’s 200-day moving average is 0.03, which suggests OTLC is a Sell.
                What is OTLC’s Williams % R (14)?
                OTLC’s Williams % R (14) is -66.67, which suggests OTLC is a Buy.
                  What is OTLC’s CCI (14)?
                  OTLC’s CCI (14) is 13.82, which suggests OTLC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis